GLIMZAL M 501

Glimzal M 501 is a combination antidiabetic medication containing Glimepiride (1 mg) and Metformin Hydrochloride SR (500 mg). Glimepiride is a sulfonylurea that stimulates pancreatic insulin secretion, while Metformin is a biguanide that improves insulin sensitivity and reduces hepatic glucose production.